This number is hard to ignore: 99% of women who receive an early breast cancer diagnosis survive the disease.
That’s what makes a new federal rule — set by the U.S. Food and Drug Administration (FDA) — that took effect on Sept. 10 so noteworthy. It requires healthcare providers to tell patients during mammography screenings how dense their breasts are, because women with dense tissue may need additional screenings to detect cancer.
While that’s a key step in the fight against the disease, the cost of those additional screenings can be prohibitive.
That concerned U.S. Rep. Rosa DeLauro (D-CT), who in May 2023 introduced a bill in Congress to address the issue. The Find It Early Act would require all health insurance plans to cover screenings and diagnostic breast imaging with no out-of-pocket costs for women with dense breasts, or who are at higher risk of breast cancer
Read the article here.
Comments